Office Of Technology Transfer- University Of Michigan

Office Of Technology Transfer- University Of Michigan Tech Transfer is responsible for the transfer of University of Michigan technology to the marketplac

U-M startup Spider9 licenses Energy Operating System (OSE) technology to  Samsung Electronics to improve their battery s...
01/08/2015

U-M startup Spider9 licenses Energy Operating System (OSE) technology to Samsung Electronics to improve their battery systems

Northville, Mich. (PRWEB) January 08, 2015 -- Agreement enables first application of Spider9’s OSE technology beyond the stationary energy storage market.

Patent granted for U-M spinout 3DBiomatrix's cell culture product
01/06/2015

Patent granted for U-M spinout 3DBiomatrix's cell culture product

3D Biomatrix, the Ann Arbor, MI-based life science startup spun out of the University of Michigan in 2010, has finally secured a U.S. patent for the techno

U-M Startup Biotectix Introduces a New Conductive Coating for Medical Devices Targeting Cardiac and Nervous System Appli...
01/06/2015

U-M Startup Biotectix Introduces a New Conductive Coating for Medical Devices Targeting Cardiac and Nervous System Applications

Biotectix, a developer of conductive coatings for medical devices that aim to optimize communication between devices and physiologic systems, introduc

12/24/2014

Universities are stepping up efforts to create “spinouts,” or startups born from cutting-edge research. Some schools are creating funds to help cover startup costs. Others are pairing scientists with entrepreneurs, launching incubators, and even including entrepreneurial activity in faculty reviews.

U-M startup Arborlight brings daylight emulation technology to market
12/22/2014

U-M startup Arborlight brings daylight emulation technology to market

Cubicle World, that mythical place where many of today’s office workers dwell, can be very dreary. These cramped little warrens are often marked by a lack

12/18/2014

U-M startup Inmatech attracts funding, hires staff

Inmatech adds staff after closing on $1.5M seed round.

U-M Startup ONL Therapeutics Strengthens Management Team
12/03/2014

U-M Startup ONL Therapeutics Strengthens Management Team

ONL Therapeutics Announces Management Team Additions By onl101 Posted December 3, 2014 In Press Release 0 Company Strengthens Leadership by Naming Chief Science Officer, Chief Medical Officer and SVP of Operations ANN ARBOR, MI – December 3, 2014 – ONL Therapeutics, Inc., a biopharmaceutical company…

U-M startup Imbio receives FDA clearance for new lung-imaging technique
12/03/2014

U-M startup Imbio receives FDA clearance for new lung-imaging technique

A technology that started in a University of Michigan Medical School lab may soon help lung disease patients around the world breathe a little easier, by giving them a clearer diagnosis and treatment plan.

U-M startup Phrixus announces European Access Program for patients with Duchenne muscular dystrophy
12/02/2014

U-M startup Phrixus announces European Access Program for patients with Duchenne muscular dystrophy

Phrixus Pharmaceuticals announces European Access Program for Carmeseal-­MD™ (P-­188 NF)for patients with Duchenne muscular dystrophy

11/24/2014

Looking for LOTS of developers for a bunch of our startups. C++, mobile, java, backend, UI/UX Email: [email protected] w/ resume and interests

U-M startup Ambiq Micro announces $15 million funding round bit.ly/1xtAseP
11/12/2014

U-M startup Ambiq Micro announces $15 million funding round bit.ly/1xtAseP

Ambiq Micro, a leader in ultra-low power integrated circuits for power-sensitive applications, today announced that it has closed a $15 million Series C funding round to accelerate the development and marketing of its SPOT™ (Subthreshold Power Optimized Technology) platform. The funding round was le…

U-M startup ONL receives $1.37M Phase II SBIR grant for development of novel retinal disease treatment
11/12/2014

U-M startup ONL receives $1.37M Phase II SBIR grant for development of novel retinal disease treatment

ONL Therapeutics Receives Phase II SBIR Grant from National Eye Institute for Development of Novel Retinal Disease Treatment By onl101 Posted November 12, 2014 In Press Release 0 ANN ARBOR, MI – November 12, 2014 – ONL Therapeutics, Inc., a biopharmaceutical company developing novel therapies for pr…

Address

1600 Huron Pkwy, Fl 2nd
Ann Arbor, MI
48105

Alerts

Be the first to know and let us send you an email when Office Of Technology Transfer- University Of Michigan posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share